Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. - Wikidata - wikimedia - TriplyDB

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

http://www.wikidata.org/entity/Q39958347

about

Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.Tips and traps analyzing pediatric PK data.What is the right dose for children?Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver Inter-individual variation in morphine clearance in children.A bodyweight-dependent allometric exponent for scaling clearance across the human life-span.Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery Pharmacological treatment of neonatal pain: in search of a new equipoise Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy?From pediatric covariate model to semiphysiological function for maturation: part I-extrapolation of a covariate model from morphine to Zidovudine.From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part II-Sensitivity to Physiological and Physicochemical Properties Adaptive trials in paediatric development: dealing with heterogeneity and uncertainty in pharmacokinetic differences in children.The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.The role of population PK-PD modelling in paediatric clinical research.Advances in paediatric pharmacokinetics.Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.Neonatal pharmacology: extensive interindividual variability despite limited size.Pharmacokinetic and pharmacogenetic determinants and considerations in chemotherapy selection and dosing in infants.Biomarkers and clinical tools in critically ill children: are we heading toward tailored drug therapy?Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?Population pharmacometrics in support of analgesics studies.Critical incidents related to opioid infusions in children: a five-year review and analysis.Drug metabolism for the paediatrician.Ethics of drug research in the pediatric intensive care unit.Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling.Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium.Paracetamol and morphine for infant and neonatal pain; still a long way to go?Morphine Pharmacodynamics in Mechanically Ventilated Preterm Neonates Undergoing Endotracheal Suctioning.Prediction of morphine dose in humans.Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.Decreased Morphine Clearance in Neonates With Hypoxic Ischemic Encephalopathy Receiving Hypothermia.

P2860

Q26786582-77DAFC7B-135A-4EE1-B5A7-5A208D929F3E Q30405534-BD411D22-CDD9-47B4-BC44-718DB5F3BF99 Q33571417-DA42BDDC-86D1-4841-8865-693175BF6C6E Q33820152-239BAF5D-7C5E-4245-AA1B-5339ECE7F818 Q34180493-67AB6619-5C6A-47B4-BCE4-4C9B8D935F42 Q34393200-07C31815-9C58-46F6-9FBD-BB9410989FC4 Q34857030-10AFDBB0-C496-4D6A-825F-2CA4C77F469D Q35595573-DC88EF56-DBB0-4B74-8A36-D8D4C449B0C1 Q35949142-C8EF0A18-A3EE-415A-BB20-04F85EAFC7A0 Q36036400-9F875975-3A08-4933-AE29-0726BF0696F6 Q36445122-8060DB50-29CD-426A-87F7-E1C08CA87D71 Q36452341-1D6A607C-07E5-4B90-844E-9F86E7BFE52E Q36568925-EE471B44-C8D1-421A-BC19-73D7830C1657 Q36621626-F6631E59-775D-476C-B76C-BB2827DEAE08 Q36702365-C6743A14-C385-402D-88E6-60AE7280AF73 Q36702370-BD4A0E15-2E2B-44CA-A965-0DCE9161228D Q36779152-985EB700-D77C-4E0A-9B54-48700B033250 Q37492046-A05D737D-5A1B-474D-B983-CE3913303CA9 Q37719346-7EF6FA75-D9AF-42E4-BCBA-FB93463ED940 Q37813680-91E274FE-D2BD-4A15-97EC-4220C2756D2C Q37872786-CA0B02F2-955E-49BA-9C12-2FB239EB8697 Q37892531-3E527C42-B649-493B-AFF6-7FA9A9CEA480 Q38000252-48FF9D3F-BCE5-4CC5-843A-4ECB6C8E5F30 Q38003177-5589673D-84A2-49F9-AABB-83291FCE8C71 Q38021511-E1251B62-9928-4CE6-93B6-E8AEB096571A Q38047202-9323DD09-CFA0-4707-A814-44EFA6717562 Q38175171-17A30372-F929-4EEB-9AFD-572FBCE99060 Q38180049-CDF6C8EA-3053-423E-AA21-4BBF5FA9E2BA Q38246000-53CA3200-C699-413B-BBFB-2782FFA5B355 Q38263726-C48F05B1-F781-4FCB-9EBC-2A63F5685CDA Q38563371-07BC6E79-C502-4EA0-8239-15E4376A3C93 Q38759413-638D7542-C0F3-4844-B0CF-2B9167218206 Q38857191-2E7F3000-BA63-4A0D-BFBE-9B65F11A1BFC Q38882590-F1F279E9-5FEC-4EBB-8761-65CE130847D0 Q38927170-86A53470-0FFF-4470-A2AA-C9896F153639 Q38992262-88F6E87E-4076-4319-A954-86018BD62DD2 Q39008582-5AD8F5FC-FE26-477D-916E-0201A3902A89 Q39668518-F55165DE-C777-4AFA-82FC-07FAA4C9AFF6 Q39683666-11A69BB5-7DA2-48DA-BDE9-F104148359FA Q39735912-F90F1A28-8D7E-4226-AA3F-C2866CBA9731

P2860

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

http://www.wikidata.org/entity/Q39958347

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

@en

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

@nl

type

label

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

@en

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

@nl

prefLabel

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

@en

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

@nl

P1433

Q39958347-39556519-9424-4AC0-93FF-ADD529C90EA4

P1476

Q39958347-58EB7A37-0B4C-4D02-AF18-87286F928C1B

P2093

Q39958347-06A94661-776A-44DF-8DA9-29BAD0C779D8

Q39958347-2666F351-7123-420E-945B-75F03779E7DA

Q39958347-295305A5-D2E3-459A-B799-F855ABF8D76F

Q39958347-473CA201-BFED-48D2-B93F-1E2FCE70B13F

Q39958347-68BC500B-C4E3-4E2A-BA89-ADFC247DFEB7

Q39958347-CD365029-A1F0-4672-9163-0D6EA7D18157

Q39958347-E9F5C7CB-7311-47A0-9BF4-5D009E6CC12E

P2860

Q39958347-6A6AF51D-3FEB-4420-96C8-5F0FDF4E8BCA

Q39958347-834F7D79-807B-4E63-BA79-074E78A6760D

Q39958347-98228533-DE02-4500-9FAC-C25D95305B60

Q39958347-C7A19C5C-8FAE-4DB1-BC91-FD1AC1025BB4

P2888

Q39958347-B504C8F0-B3CC-4E1C-BE8B-D92CE679F0C6

P304

Q39958347-FD99307D-A816-492A-9D70-24E51D2D4762

P31

Q39958347-C23136C5-2656-4BE3-AF91-A010EDB78871

P356

Q39958347-AD9A5FD8-6661-4B7B-8BD5-19E2BD615869

P433

Q39958347-06BC6F9C-CF2F-4873-B64C-911E19E4706B

P478

Q39958347-92B853ED-25E3-42FB-94BC-0DAAEFC9B263

P50

Q39958347-41D7B968-9BAF-4067-A311-DB55C6AC7D17

Q39958347-83B9AF71-A328-4E71-B8DC-E64F15C0F1BA

Q39958347-B4FE3095-62E6-4545-B3AF-0AD1C28D23B2

Q39958347-D578B23E-0642-49E0-864A-BEC6D6957AA0

P577

Q39958347-D5C137D3-C690-4BAA-BF8E-8F71716A11D5

P6179

Q39958347-947F6E50-E933-4C2A-9780-CC07D35F0AD0

P698

Q39958347-9BF83533-6976-479C-B407-CB652F330C31

P921

Q39958347-21A87479-8F85-4137-8703-DEE079689138

P356

00003088-200948060-00003

P1433

Clinical Pharmacokinetics

P1476

Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.

@en

P2093

Catherijne A J Knibbe

http://www.w3.org/2001/XMLSchema#string

Elke H J Krekels

http://www.w3.org/2001/XMLSchema#string

Gijs W E Santen

http://www.w3.org/2001/XMLSchema#string

Johannes N van den Anker

http://www.w3.org/2001/XMLSchema#string

Meindert Danhof

http://www.w3.org/2001/XMLSchema#string

Richard A van Lingen

http://www.w3.org/2001/XMLSchema#string

Sinno H P Simons

http://www.w3.org/2001/XMLSchema#string

P2860

The analgesic activity of morphine-6-glucuronide.

Morphine sulphation in children

Morphine metabolism in neonates and infants.

Pharmacokinetic-pharmacodynamic relationships of morphine in neonates.

P2888

00003088-200948060-00003

P304

371-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/00003088-200948060-00003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Evelyne Jacqz-Aigrain

Monique van Dijk

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015423758

http://www.w3.org/2001/XMLSchema#string

P698

19650676

http://www.w3.org/2001/XMLSchema#string

P921